Search research articles
Contact Us
Filters
Showing results (91-100 of 224) with videos related to
Page
of 23
Sort By:
Frontiers in Oncology
|
July 21, 2023
Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an <i>EGFR</i> mutation in tissue: a UK pilot study
Helen Brooks, Ling Li, Alfredo Addeo, et al.
Ecancermedicalscience
|
July 19, 2017
Brain imaging before primary lung cancer resection: a controversial topic
Zoe Hudson, Eveline Internullo, Anthony Edey, et al.
Journal of Cancer Policy
|
June 3, 2023
Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022
Timothée Olivier, Claire E P Smith, Alyson Haslam, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 15, 2025
Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back
Annapaola Mariniello, Maxime Borgeaud, Marc Weiner, et al.
Journal of Clinical Medicine
|
March 11, 2023
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
Maxime Borgeaud, Floryane Kim, Alex Friedlaender, et al.
Cancer Treatment Reviews
|
January 30, 2022
Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC
Alex Friedlaender, Jarushka Naidoo, Giuseppe Luigi Banna, et al.
International Journal of Molecular Sciences
|
September 4, 2020
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Alex Friedlaender, Alfredo Addeo, Alessandro Russo, et al.
Clinical Lung Cancer
|
June 6, 2020
The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors
Alex Friedlaender, Stephen V Liu, Antonio Passaro, et al.
Cancer Investigation
|
August 19, 2021
Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy
Giuseppe Luigi Banna, Ornella Cantale, Alex Friedlaender, et al.
International Journal of Molecular Sciences
|
July 29, 2023
Neoadjuvant Immunotherapy: A Promising New Standard of Care
Emma Boydell, Jose L Sandoval, Olivier Michielin, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 224) with videos related to
Sort By:
Page
of 23
Frontiers in Oncology
|
July 21, 2023
Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an <i>EGFR</i> mutation in tissue: a UK pilot study
Helen Brooks, Ling Li, Alfredo Addeo, et al.
Ecancermedicalscience
|
July 19, 2017
Brain imaging before primary lung cancer resection: a controversial topic
Zoe Hudson, Eveline Internullo, Anthony Edey, et al.
Journal of Cancer Policy
|
June 3, 2023
Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022
Timothée Olivier, Claire E P Smith, Alyson Haslam, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 15, 2025
Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back
Annapaola Mariniello, Maxime Borgeaud, Marc Weiner, et al.
Journal of Clinical Medicine
|
March 11, 2023
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
Maxime Borgeaud, Floryane Kim, Alex Friedlaender, et al.
Cancer Treatment Reviews
|
January 30, 2022
Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC
Alex Friedlaender, Jarushka Naidoo, Giuseppe Luigi Banna, et al.
International Journal of Molecular Sciences
|
September 4, 2020
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Alex Friedlaender, Alfredo Addeo, Alessandro Russo, et al.
Clinical Lung Cancer
|
June 6, 2020
The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors
Alex Friedlaender, Stephen V Liu, Antonio Passaro, et al.
Cancer Investigation
|
August 19, 2021
Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy
Giuseppe Luigi Banna, Ornella Cantale, Alex Friedlaender, et al.
International Journal of Molecular Sciences
|
July 29, 2023
Neoadjuvant Immunotherapy: A Promising New Standard of Care
Emma Boydell, Jose L Sandoval, Olivier Michielin, et al.
Page
of 23